1. Monti C, Bondi H, Urbani A, Fasano M, Alberio T*. Systems biology analysis of the proteomic alterations induced by MPP(+), a Parkinson's disease-related mitochondrial toxin. Front Cell Neurosci. 2015;9:14.
*corresponding author
2. Alberio T, Mammucari C, D'Agostino G, Rizzuto R, Fasano M. Altered dopamine homeostasis differentially affects mitochondrial voltage-dependent anion channels turnover. Biochim Biophys Acta. 2014;1842(9):1816-22.
3. Alberio T*, McMahon K, Cuccurullo M, Gethings LA, Lawless C, Zibetti M, Lopiano L, Vissers JP, Fasano M. Verification of a Parkinson's disease protein signature in T-lymphocytes by multiple reaction monitoring. J Proteome Res. 2014 Aug 1;13(8):3554-61.
*corresponding author
4. Alberio T, Bondi H, Colombo F, Alloggio I, Pieroni L, Urbani A, Fasano M. Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis. Mol. BioSyst., 2014, 10(6): 1332-44.
5. Ascenzi P, di Masi A, Leboffe L, Alberio T, Fanali G, Fasano M. Molecular phylogenetic analyses of albuminoids reveal the molecular evolution of allosteric properties. IUBMB Life. 2013; 65(6):544-9.
6. Falvella FS, Alberio T, Noci S, Santambrogio L, Nosotti M, Incarbone M, Pastorino U, Fasano M, Dragani TA. Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma. Carcinogenesis. 2013; 34(6):1281-5.
7. Alberio T, Bucci EM, Natale M, Bonino D, Di Giovanni M, Bottacchi E, Fasano M. Parkinson's disease plasma biomarkers: an automated literature analysis followed by experimental validation. J Proteomics. 2013; 90:107-14.
8. Alberio T, Pippione AC, Zibetti M, Olgiati S, Cecconi D, Comi C, Lopiano L,Fasano M. Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease. Sci Rep. 2012; 2:953.
9. Polati R, Castagna A, Bossi AM, Alberio T, De Domenico I, Kaplan J, Timperio AM, Zolla L, Gevi F, D'Alessandro A, Brunch R, Olivieri O, Girelli D. Murine macrophages response to iron. J Proteomics. 2012; 76 Spec No.:10-27.
10. Alberio T*, Pippione AC, Comi C, Olgiati S, Cecconi D, Zibetti M, Lopiano L, Fasano M. Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease. IUBMB Life. 2012; 64(10):846-52.
*corresponding author
11. Alberio T, Lopiano L, Fasano M. Cellular models to investigate biochemical pathways in Parkinson's disease. FEBS J. 2012; 279(7):1146-55.
12. Alberio T, Fasano M. Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies. J Biotechnol. 2010 Dec 20;156(4):325-37.
13. Alberio T, Anchieri C, Piacentini L, Gentile G, Simmaco M, Biasin M, Fasano M. Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells. Biochimie. 2011; 93(5):892-8.
14. Alberio T, Bossi AM, Milli A, Parma E, Gariboldi MB, Tosi G, Lopiano L, Fasano M. Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis. FEBS J. 2010; 277(23):4909-19.
15. Alberio T, Colapinto M, Natale M, Ravizza R, Gariboldi MB, Bucci EM, Lopiano L, Fasano M. Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment. IUBMB Life. 2010; 62(9):688-92.
16. Natale M, Bonino D, Consoli P, Alberio T, Ravid RG, Fasano M, Bucci EM. A meta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1. Bioinformatics. 2010; 26(7):946-52.
17. Rubino T, Realini N, Braida D, Alberio T, Capurro V, Viganò D, Guidali C,Sala M, Fasano M, Parolaro D. The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex. Neurotox Res. 2009; 15(4):291-302.
18. Marrazzo E, Marchini S, Tavecchio M, Alberio T, Previdi S, Erba E, Rotter V, Broggini M. The expression of the DeltaNp73beta isoform of p73 leads to tetraploidy. Eur J Cancer. 2009; 45(3):443-53.
19. Fasano M, Alberio T, Lopiano L. Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration. Biomark Med. 2008; 2(5):465-78.
20. Fasano M, Alberio T, Colapinto M, Mila S, Lopiano L. Proteomics as a tool to investigate cell models for dopamine toxicity. Parkinsonism Relat Disord. 2008;14 Suppl 2:S135-8.
